Home » Topics » Medical technology

Medical technology
RSS

Today's MDD food for med-tech thought

Nov. 13, 2007

Ecolab seals $275M Microtek buy; Genzyme buys DG unit for $56.5M

Nov. 13, 2007

For tonsil/adenoid removal, PITA procedures offer faster recovery

Nov. 13, 2007

LinkMed invests in Swedish fluid measurement developer

Nov. 13, 2007

Exact gets warning for cancer test used outside ‘home brew’ rules

Nov. 13, 2007

By Mark McCarty

VRC looks to raise $82.8M in IPO; ART closes on private $7.8 million

Nov. 13, 2007

By Holland Johnson

Covidien to acquire Scandius Bio; Arteriocyte to buy Magellan system

Nov. 12, 2007

Briefly Noted

Nov. 12, 2007

Inverness puts 7M shares on shelf; Derma Sciences raises $20 million

Nov. 12, 2007

Today's MDD food for med-tech thought

Nov. 12, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
Roche reports new TREM2 agonists
BioWorld Science
F. Hoffmann-la Roche Ltd. and Hoffmann-La Roche Inc. have identified new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for...
Genescience presents STAT6 degrader for atopic dermatitis
BioWorld Science
Genescience Pharmaceutical Co. Ltd. has presented data on a new STAT6 PROTAC degrader – GenSciP166 – which selectively targets STAT6 for proteasomal degradation....
Recludix’s first-in-class STAT6 inhibitor shows efficacy in atopic dermatitis
BioWorld Science
Researchers from Recludix Pharma Inc. reported preclinical efficacy data on REX-8756 (SAR-448755), a first-in-class orthosteric STAT6 inhibitor in models of...